FutureFuel Corp. (FF) is a small-cap specialty chemicals and biofuels producer that manufactures biodiesel from renewable feedstocks alongside a portfolio of performance chemicals. The stock has drawn occasional attention from value-oriented investors because of its modest valuation and historical profitability, but it remains one of the most thinly covered names on the NYSE. That thin coverage is central to answering whether a move toward a $14 stock price target is realistic.
FutureFuel's analyst coverage is extraordinarily thin, which prevents the calculation of a meaningful average analyst price target. Market data providers list only a single current 12-month objective of $14.00, reported without a clearly attributable firm or date in the aggregators reviewed. A separate, older figure of $1.20 from H.C. Wainwright (dated June 2026) sits far below the prevailing market price and appears inconsistent with current conditions, so it is not relied upon here.
Because fewer than two credible, current, and verifiable targets exist, the $14 figure is best understood as a publicly discussed price objective rather than a genuine "analyst consensus." Weiss Ratings, in contrast, has maintained a Sell view on the name, underscoring how divided and incomplete the external research picture is. Investors should therefore treat the $14 level as a directional reference point, not as a broadly vetted Street forecast.
FutureFuel has recently traded near $5.70, within a 52-week range of roughly $3.09 to $6.99. Reaching $14 would require a gain of approximately 146% from that level — a very large move for a company of this size and one that is more than double its 52-week high. Such a re-rating would typically require not just improved fundamentals but a material change in how the market values the business.
The path would likely depend on sustained earnings growth, expanding margins in specialty chemicals, and a favorable renewable-fuels backdrop. With a market capitalization of only a few hundred million dollars and limited trading liquidity, the stock can also swing sharply on modest news flow, meaning the gap between the current price and a $14 objective could narrow — or widen — on catalysts rather than steady appreciation.
The most credible supports are structural rather than event-driven. FutureFuel operates a diversified model that pairs biodiesel production with a specialty chemicals segment, which can smooth results across commodity cycles. Its valuation has historically been undemanding, and steady cash generation supports the business. Broader demand for renewable fuels and bio-based chemicals, reinforced by U.S. policy frameworks and corporate sustainability goals, provides a long-term demand backdrop. If earnings inflect higher and coverage deepens, a re-rating toward higher levels becomes more plausible.
Several factors argue for caution. Biodiesel margins are sensitive to feedstock costs and fuel prices, and the industry is exposed to policy shifts around biofuel tax credits and blending mandates. The specialty chemicals business faces its own competitive and input-cost pressures. Critically, the absence of broad analyst sponsorship means there is little institutional re-rating support, and Weiss Ratings' Sell view signals that at least one research provider sees downside risk. Small-cap liquidity and the possibility of dilution also weigh against a sustained multi-fold advance.
From a technical standpoint, the $6.99 52-week high represents the nearest notable resistance level, while the $3.09 low marks major support. The stock has recently traded mid-range, leaving clear overhead supply between current levels and the prior high. Because the $14 objective is more than twice the 52-week high, there is no near-term technical anchor for it; any advance would first need to reclaim and hold above $6.99 before higher targets become technically relevant.
Analyst price targets typically reflect a roughly 12-month research horizon, though with a single thinly sourced figure, no reliable horizon can be confirmed here. Investors should monitor quarterly earnings and guidance, feedstock and fuel-price trends, and any regulatory developments affecting biofuel credits and blending requirements. Equally important is whether sell-side coverage expands or contracts, since additional research initiation — or further downgrades — could materially influence how the $14 objective is viewed.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. Rather than relying on a single analyst's view, this tool helps traders screen for opportunities, track existing positions, and identify shifting trends more efficiently. For those following FutureFuel, such signals can offer a data-driven complement to fundamental research and price-target analysis.
Reaching $14 would require FutureFuel to appreciate roughly 146% from recent levels — a very large move with only a single, thinly sourced public price objective behind it. The bull case rests on a low valuation, a diversified chemicals-and-biofuels model, and long-term renewable-fuels demand; the bear case points to commodity and policy volatility, a Sell rating from Weiss Ratings, and almost no institutional research support. With no verifiable consensus, the $14 figure is best treated as an aspirational reference point, and investors should watch earnings, feedstock costs, biofuel policy, and any changes in analyst coverage before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, FF has been loosely correlated with VHI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if FF jumps, then VHI could also see price increases.